Related Experiment Video
Updated: Jan 8, 2026

06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
8.1K
Reply to "Comment on 'Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment'"
Tamaki Kato1, Noriko Otsuki1, Mamoru Yokomura1
1Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
Brain & Development
|December 23, 2025
Abstract
No abstract available in PubMed .

